Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00141115Phase 2Completed
Phase 2, open-label, single-arm trial of levetiracetam in alcohol dependence, sponsored by New York State Psychiatric Institute. Primary endpoint: Participants Who Reported Reductions in Alcohol Consumption at 9 weeks. Started Mar 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00141115.